Stay Informed on Corporate Sustainability
Explore industry news, insights, and updates from the Pharma Life Science Awards.
Automation unlocks agility in microbiome and biotech R&D
Author: News-Medical
For pharma leaders chasing faster discovery and scale, manual colony picking has long been a bottleneck, slow, error-prone, and resource-intensive.
Regeneron’s $256m genetics play signals a deeper bet on precision health
Author: PMLive
Regeneron is set to acquire the core assets of 23andMe for $256 million, absorbing its genome services, biobank, and research operations following the latter’s bankruptcy proceedings.
Digitise manufacturing with Peak Technologies
Author: April Lara
Peak Technologies helps you streamline production, reduce errors, and stay ahead with intelligent MES solutions.
Celebrating Excellence at the Pharma Industry Awards 2024
Author: Pharma Industry Awards
The Pharma Industry Awards 2024 showcased remarkable achievements, innovation, and leadership within the pharmaceutical sector.
Pharma Industry Awards 2024 – Relive the Highlights
Author: Pharma Industry Awards
The Pharma Industry Awards 2024 celebrated excellence, innovation, and achievement across the pharmaceutical sector on Wednesday, 30th October 2024.
Honouring Excellence at the Pharma Industry Awards 2024
Author: Pharma Industry Awards
The Pharma Industry Awards 2024 marked an extraordinary evening celebrating the stellar achievements of individuals, companies, and organisations that continue to propel the pharmaceutical industry forward.
Meet the 2024 Pharma Industry Awards Winners
Author: April Lara
Watch the Winner's Circle video to celebrate the outstanding achievements of the 2024 Pharma Industry Awards winners.
Regulatory headwinds amidst M&A boom in Irish life sciences
Author: April Lara
M&A deals are heating up in Ireland's life sciences sector. But can companies navigate the challenges with growing regulations and AI's impact?
Are public-private partnerships the future of clinical trials?
Author: April Lara
Public-private partnerships are reshaping clinical trials. Ireland’s new oversight group and the VPAG investment programme aim to boost efficiency and attract global research.
Pharma and DTx for better patient care
Author: April Lara
Regulatory winds are blowing in favour of DTx, which could benefit pharma companies significantly.


Explore our newsletters
Join our Newsletter to receive the latest industry trends, expert tips, and exclusive insights delivered straight to your inbox!
